Allergy Immunotherapy Market by Type and Distribution Channel - Global Industry Analysis & Forecast to 2027

Published On : August 2020 Pages : 180 Category: Healthcare IT Report Code : HC0812455

Allergy Immunotherapy Market by Type (Subcutaneous Immunotherapy (SCIT), Sublingual Immunotherapy (SLIT) Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) - Global Industry Analysis & Forecast to 2027

Industry Outlook and Trend Analysis

The Allergy Immunotherapy Market has encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period. Allergy Immunotherapy involves injecting the allergen(s), causing the allergy symptoms. These allergens are identified by a combination of a medical evaluation performed by a trained allergist / immunologist and allergy skin or allergy blood tests.

Drivers and Restraints

Top-down and bottom-up approaches are used to validate the global market and estimate the market size for company, regions segments, type segments and applications (end users). In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.

Regional Insights

The data for 2019 is an estimate, based on the history data and the integrated view of industry experts, manufacturers, distributors and end users etc.

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Italy
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • India
    • Southeast Asia
    • Rest of Asia-Pacific
  • South America
    • Brazil
    • Argentina
    • Columbia
    • Rest of South America
  • Middle East and Africa
    • Saudi Arabia
    • UAE
    • Egypt
    • Nigeria
    • South Africa
    • Rest of MEA

Competitive Analysis         

The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.

  • ASIT Biotech
  • Circassia
  • Mylan N.V.
  • Adamis Pharmaceuticals Corporation
  • Merck KGaA
  • Stallergenes Greer plc
  • Allergy Therapeutics
  • ALK-Abelló A/S
  • DESENTUM OY
  • HAL Allergy B.V.
  • HollisterStier Allergy

Some of the key questions answered by the report are:

  • What was the market size in 2016 and forecast from 2020 to 2027?
  • What will be the industry market growth from 2016 to 2027?
  • What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
  • What are the major segments leading the market growth and why?
  • Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?

Market Classification

·         Allergy Immunotherapy Market, By Type, Estimates and Forecast, 2016-2027 ($Million)

o    Subcutaneous Immunotherapy (SCIT)

o    Sublingual Immunotherapy (SLIT)

·         Allergy Immunotherapy Market, By Distribution Channel Estimates and Forecast, 2016-2027 ($Million)

o    Hospital Pharmacy

o    Retail Pharmacy

o    Online Pharmacy

·         Allergy Immunotherapy Market, By Key Players, Estimates and Forecast, 2016-2027 ($Million)

o    ASIT Biotech

o    Circassia

o    Mylan N.V.

o    Adamis Pharmaceuticals Corporation

o    Merck KGaA

o    Stallergenes Greer plc

o    Allergy Therapeutics

o    ALK-Abelló A/S

o    DESENTUM OY

o    HAL Allergy B.V.

o    HollisterStier Allergy

·         Allergy Immunotherapy Market, By Region, Estimates and Forecast, 2016-2027 ($Million)

o    North America

§  North America Allergy Immunotherapy Market , By Country

o    U.S. Allergy Immunotherapy Market

o    Canada Allergy Immunotherapy Market

o    Mexico Allergy Immunotherapy Market

o    Europe

§  Europe Allergy Immunotherapy Market , By Country

o    Germany Allergy Immunotherapy Market

o    UK Allergy Immunotherapy Market

o    France Allergy Immunotherapy Market

o    Russia Allergy Immunotherapy Market

o    Italy Allergy Immunotherapy Market

o    Rest of Europe Allergy Immunotherapy Market

o    Asia-Pacific

§  Asia-Pacific Allergy Immunotherapy Market , By Country

o    China Allergy Immunotherapy Market

o    Japan Allergy Immunotherapy Market

o    South Korea Allergy Immunotherapy Market

o    India Allergy Immunotherapy Market

o    Southeast Asia Allergy Immunotherapy Market

o    Rest of Asia-Pacific Allergy Immunotherapy Market

o    South America

§  South America Allergy Immunotherapy Market , By Country

o    Brazil Allergy Immunotherapy Market

o    Argentina Allergy Immunotherapy Market

o    Columbia Allergy Immunotherapy Market

o    Rest of South America Allergy Immunotherapy Market

o    Middle East and Africa

§  Middle East and Africa Allergy Immunotherapy Market , By Country

o    Saudi Arabia Allergy Immunotherapy Market

o    UAE Allergy Immunotherapy Market

o    Egypt Allergy Immunotherapy Market

o    Nigeria Allergy Immunotherapy Market

o    South Africa Allergy Immunotherapy Market

o    Rest of MEA Allergy Immunotherapy Market

Table of Contents:

1.       Introduction

1.1.     Report Description

2.       Executive Summary

2.1.     Key Highlights

3.       Market Overview

3.1.     Introduction

3.1.1.  Market Definition

3.1.2.  Market Segmentation

3.2.     Market Dynamics

3.2.1.  Drivers

3.2.2.  Restraints

3.2.3.  Opportunities

4.       Market Analysis by Regions

4.1.     North America (United States, Canada and Mexico)

4.1.1.  United States Market Status and Outlook (2016-2027)

4.1.2.  Canada Market Status and Outlook (2016-2027)

4.1.3.  Mexico Market Status and Outlook (2016-2027)

4.2.     Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

4.2.1.  Germany Market Status and Outlook (2016-2027)

4.2.2.  France Market Status and Outlook (2016-2027)

4.2.3.  UK Market Status and Outlook (2016-2027)

4.2.4.  Russia Market Status and Outlook (2016-2027)

4.2.5.  Italy Market Status and Outlook (2016-2027)

4.2.6.  Rest of Europe Market Status and Outlook (2016-2027)

4.3.     Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)

4.3.1.  China Market Status and Outlook (2016-2027)

4.3.2.  Japan Market Status and Outlook (2016-2027)

4.3.3.  Korea Market Status and Outlook (2016-2027)

4.3.4.  India Market Status and Outlook (2016-2027)

4.3.5.  Southeast Asia Market Status and Outlook (2016-2027)

4.3.6.  Rest of Asia-Pacific Market Status and Outlook (2016-2027)

4.4.     South America (Brazil, Argentina, Columbia and Rest of South America)

4.4.1.  Brazil Market Status and Outlook (2016-2027)

4.4.2.  Argentina Market Status and Outlook (2016-2027)

4.4.3.  Columbia Market Status and Outlook (2016-2027)

4.4.4.  Rest of South America Market Status and Outlook (2016-2027)

4.5.     Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)

4.5.1.  Saudi Arabia Market Status and Outlook (2016-2027)

4.5.2.  United Arab Emirates Market Status and Outlook (2016-2027)

4.5.3.  Egypt Market Status and Outlook (2016-2027)

4.5.4.  Nigeria Market Status and Outlook (2016-2027)

4.5.5.  South Africa Market Status and Outlook (2016-2027)

4.5.6.  Turkey Market Status and Outlook (2016-2027)

4.5.7.  Rest of Middle East and Africa Market Status and Outlook (2016-2027)

5.       Allergy Immunotherapy  Market, By Type

5.1.     Introduction

5.2.     Global Allergy Immunotherapy  Revenue and Market Share by Type (2016-2019)

5.2.1.  Global Allergy Immunotherapy  Revenue and Revenue Share by Type (2016-2019)

5.3.     Subcutaneous Immunotherapy (SCIT)

5.3.1.  Global Subcutaneous Immunotherapy (SCIT) Revenue and Growth Rate (2016-2019)

5.4.     Sublingual Immunotherapy (SLIT)

5.4.1.  Global Sublingual Immunotherapy (SLIT) Revenue and Growth Rate (2016-2019)

6.       Allergy Immunotherapy  Market, By Distribution Channel

6.1.     Introduction

6.2.     Global Allergy Immunotherapy  Revenue and Market Share by Distribution Channel (2016-2019)

6.2.1.  Global Allergy Immunotherapy  Revenue and Revenue Share by Distribution Channel (2016-2019)

6.3.     Hospital Pharmacy

6.3.1.  Global Hospital Pharmacy Revenue and Growth Rate (2016-2019)

6.4.     Retail Pharmacy

6.4.1.  Global Retail Pharmacy Revenue and Growth Rate (2016-2019)

6.5.     Online Pharmacy

6.5.1.  Global Online Pharmacy Revenue and Growth Rate (2016-2019)

7.       Allergy Immunotherapy  Market, By Region

7.1.     Introduction

7.2.     Global Allergy Immunotherapy  Revenue and Market Share by Regions

7.2.1.  Global Allergy Immunotherapy  Revenue by Regions (2016-2019)

7.3.     North America Allergy Immunotherapy  by Countries

7.3.1.  North America Allergy Immunotherapy  Revenue and Growth Rate (2016-2019)

7.3.2.  North America Allergy Immunotherapy  Revenue (Million USD) by Countries (2016-2019)

7.3.3.  United States

7.3.3.1.  United States Allergy Immunotherapy  Revenue (Millions USD) and Growth Rate (2016-2019)

7.3.4.  Canada

7.3.4.1.  Canada Allergy Immunotherapy  Revenue (Millions USD) and Growth Rate (2016-2019)

7.3.5.  Mexico

7.3.5.1.  Mexico Allergy Immunotherapy  Revenue (Millions USD) and Growth Rate (2016-2019)

7.4.     Europe Allergy Immunotherapy  by Countries

7.4.1.  Europe Allergy Immunotherapy  Revenue and Growth Rate (2016-2019)

7.4.2.  Europe Allergy Immunotherapy  Revenue (Million USD) by Countries (2016-2019)

7.4.3.  Germany

7.4.3.1.  Germany Allergy Immunotherapy  Revenue (Millions USD) and Growth Rate (2016-2019)

7.4.4.  France

7.4.4.1.  France Allergy Immunotherapy  Revenue (Millions USD) and Growth Rate (2016-2019)

7.4.5.  UK

7.4.5.1.  UK Allergy Immunotherapy  Revenue (Millions USD) and Growth Rate (2016-2019)

7.4.6.  Russia

7.4.6.1.  Russia Allergy Immunotherapy  Revenue (Millions USD) and Growth Rate (2016-2019)

7.4.7.  Italy

7.4.7.1.  Italy Allergy Immunotherapy  Revenue (Millions USD) and Growth Rate (2016-2019)

7.4.8.  Rest of Europe

7.4.8.1.  Rest of Europe Allergy Immunotherapy  Revenue (Millions USD) and Growth Rate (2016-2019)

7.5.     Asia-Pacific Allergy Immunotherapy  by Countries

7.5.1.  Asia-Pacific Allergy Immunotherapy  Revenue and Growth Rate (2016-2019)

7.5.2.  Asia-Pacific Allergy Immunotherapy  Revenue (Million USD) by Countries (2016-2019)

7.5.3.  China

7.5.3.1.  China Allergy Immunotherapy  Revenue (Millions USD) and Growth Rate (2016-2019)

7.5.4.  Japan

7.5.4.1.  Japan Allergy Immunotherapy  Revenue (Millions USD) and Growth Rate (2016-2019)

7.5.5.  Korea

7.5.5.1.  Korea Allergy Immunotherapy  Revenue (Millions USD) and Growth Rate (2016-2019)

7.5.6.  India

7.5.6.1.  India Allergy Immunotherapy  Revenue (Millions USD) and Growth Rate (2016-2019)

7.5.7.  Southeast Asia

7.5.7.1.  Southeast Asia Allergy Immunotherapy  Revenue (Millions USD) and Growth Rate (2016-2019)

7.5.8.  Rest of Asia-Pacific

7.5.8.1.  Rest of Asia-Pacific Allergy Immunotherapy  Revenue (Millions USD) and Growth Rate (2016-2019)

7.6.     South America Allergy Immunotherapy  by Countries

7.6.1.  South America Allergy Immunotherapy  Revenue and Growth Rate (2016-2019)

7.6.2.  South America Allergy Immunotherapy  Revenue (Million USD) by Countries (2016-2019)

7.6.3.  Brazil

7.6.3.1.  Brazil Allergy Immunotherapy  Revenue (Millions USD) and Growth Rate (2016-2019)

7.6.4.  Argentina

7.6.4.1.  Argentina Allergy Immunotherapy  Revenue (Millions USD) and Growth Rate (2016-2019)

7.6.5.  Columbia

7.6.5.1.  Columbia Allergy Immunotherapy  Revenue (Millions USD) and Growth Rate (2016-2019)

7.6.6.  Rest of South America

7.6.6.1.  Rest of South America Allergy Immunotherapy  Revenue (Millions USD) and Growth Rate (2016-2019)

7.7.     Middle East and Africa Allergy Immunotherapy  by Countries

7.7.1.  Middle East and Africa Allergy Immunotherapy  Revenue and Growth Rate (2016-2019)

7.7.2.  Middle East and Africa Allergy Immunotherapy  Revenue (Million USD) by Countries (2016-2019)

7.7.3.  Saudi Arabia

7.7.3.1.  Saudi Arabia Allergy Immunotherapy  Revenue (Millions USD) and Growth Rate (2016-2019)

7.7.4.  United Arab Emirates

7.7.4.1.  United Arab Emirates Allergy Immunotherapy  Revenue (Millions USD) and Growth Rate (2016-2019)

7.7.5.  Egypt

7.7.5.1.  Egypt Allergy Immunotherapy  Revenue (Millions USD) and Growth Rate (2016-2019)

7.7.6.  Nigeria

7.7.6.1.  Nigeria Allergy Immunotherapy  Revenue (Millions USD) and Growth Rate (2016-2019)

7.7.7.  South Africa

7.7.7.1.  South Africa Allergy Immunotherapy  Revenue (Millions USD) and Growth Rate (2016-2019)

7.7.8.  Turkey

7.7.8.1.  Turkey Allergy Immunotherapy  Revenue (Millions USD) and Growth Rate (2016-2019)

7.7.9.  Rest of Middle East and Africa

7.7.9.1.  Rest of Middle East and Africa Allergy Immunotherapy  Revenue (Millions USD) and Growth Rate (2016-2019)

8.       Company Profiles

8.1.     ASIT Biotech

8.1.1.  Business Overview

8.1.2.   Service Portfolio

8.1.3.  Strategic Developments

8.1.4.  Financial Overview

8.2.     Circassia

8.2.1.  Business Overview

8.2.2.   Service Portfolio

8.2.3.  Strategic Developments

8.2.4.  Financial Overview

8.3.     Mylan N.V.

8.3.1.  Business Overview

8.3.2.   Service Portfolio

8.3.3.  Strategic Developments

8.3.4.  Financial Overview

8.4.     Adamis Pharmaceuticals Corporation

8.4.1.  Business Overview

8.4.2.   Service Portfolio

8.4.3.  Strategic Developments

8.4.4.  Financial Overview

8.5.     Merck KGaA

8.5.1.  Business Overview

8.5.2.   Service Portfolio

8.5.3.  Strategic Developments

8.5.4.  Financial Overview

8.6.     Stallergenes Greer plc

8.6.1.  Business Overview

8.6.2.   Service Portfolio

8.6.3.  Strategic Developments

8.6.4.  Financial Overview

8.7.     Allergy Therapeutics

8.7.1.  Business Overview

8.7.2.   Service Portfolio

8.7.3.  Strategic Developments

8.7.4.  Financial Overview

8.8.     ALK-Abelló A/S

8.8.1.  Business Overview

8.8.2.   Service Portfolio

8.8.3.  Strategic Developments

8.8.4.  Financial Overview

8.9.     DESENTUM OY

8.9.1.  Business Overview

8.9.2.   Service Portfolio

8.9.3.  Strategic Developments

8.9.4.  Financial Overview

8.10. HAL Allergy B.V.

8.10.1.      Business Overview

8.10.2.       Service Portfolio

8.10.3.      Strategic Developments

8.10.4.      Financial Overview

8.11. HollisterStier Allergy

8.11.1.      Business Overview

8.11.2.       Service Portfolio

8.11.3.      Strategic Developments

8.11.4.      Financial Overview

9.       Allergy Immunotherapy  Market Forecast (2019-2027)

9.1.     Global Allergy Immunotherapy  Revenue (Millions USD) and Growth Rate (2019-2027)

9.2.     Allergy Immunotherapy  Market Forecast by Regions (2019-2027)

9.2.1.  North America Allergy Immunotherapy  Market Forecast (2019-2027)

9.2.1.1.  United States Allergy Immunotherapy  Market Forecast (2019-2027)

9.2.1.2.  Canada Allergy Immunotherapy  Market Forecast (2019-2027)

9.2.1.3.  Mexico Allergy Immunotherapy  Market Forecast (2019-2027)

9.2.2.  Europe Allergy Immunotherapy  Market Forecast (2019-2027)

9.2.2.1.  Germany Allergy Immunotherapy  Market Forecast (2019-2027)

9.2.2.2.  France Allergy Immunotherapy  Market Forecast (2019-2027)

9.2.2.3.  UK Allergy Immunotherapy  Market Forecast (2019-2027)

9.2.2.4.  Russia Allergy Immunotherapy  Market Forecast (2019-2027)

9.2.2.5.  Italy Allergy Immunotherapy  Market Forecast (2019-2027)

9.2.2.6.  Rest of Europe Allergy Immunotherapy  Market Forecast (2019-2027)

9.2.3.  Asia-Pacific Allergy Immunotherapy  Market Forecast (2019-2027)

9.2.3.1.  China Allergy Immunotherapy  Market Forecast (2019-2027)

9.2.3.2.  Japan Allergy Immunotherapy  Market Forecast (2019-2027)

9.2.3.3.  Korea Allergy Immunotherapy  Market Forecast (2019-2027)

9.2.3.4.  India Allergy Immunotherapy  Market Forecast (2019-2027)

9.2.3.5.  Southeast Asia Allergy Immunotherapy  Market Forecast (2019-2027)

9.2.3.6.  Rest of Asia-Pacific Allergy Immunotherapy  Market Forecast (2019-2027)

9.2.4.  South America Allergy Immunotherapy  Market Forecast (2019-2027)

9.2.4.1.  Brazil Allergy Immunotherapy  Market Forecast (2019-2027)

9.2.4.2.  Argentina Allergy Immunotherapy  Market Forecast (2019-2027)

9.2.4.3.  Columbia Allergy Immunotherapy  Market Forecast (2019-2027)

9.2.4.4.  Rest of South America Allergy Immunotherapy  Market Forecast (2019-2027)

9.2.5.  Middle East and Africa Allergy Immunotherapy  Market Forecast (2019-2027)

9.2.5.1.  Saudi Arabia Allergy Immunotherapy  Market Forecast (2019-2027)

9.2.5.2.  United Arab Emirates Allergy Immunotherapy  Market Forecast (2019-2027)

9.2.5.3.  Egypt Allergy Immunotherapy  Market Forecast (2019-2027)

9.2.5.4.  Nigeria Allergy Immunotherapy  Market Forecast (2019-2027)

9.2.5.5.  South Africa Allergy Immunotherapy  Market Forecast (2019-2027)

9.2.5.6.  Turkey Allergy Immunotherapy  Market Forecast (2019-2027)

9.2.5.7.  Rest of Middle East and Africa Allergy Immunotherapy  Market Forecast (2019-2027)

9.3.     Allergy Immunotherapy  Market Forecast by Type (2019-2027)

9.3.1.  Allergy Immunotherapy  Forecast by Type (2019-2027)

9.3.2.  Allergy Immunotherapy  Market Share Forecast by Type (2019-2027)

9.4.     Allergy Immunotherapy  Market Forecast by Distribution Channel (2019-2027)

9.4.1.  Allergy Immunotherapy  Forecast by Distribution Channel (2019-2027)

9.4.2.  Allergy Immunotherapy  Market Share Forecast by Distribution Channel (2019-2027)


List of Tables

List of Tables and Figures:

Figure United States Allergy Immunotherapy Revenue (Million USD) and Growth Rate (2016-2027)
Figure Canada Allergy Immunotherapy Revenue (Million USD) and Growth Rate (2016-2027)
Figure Mexico Allergy Immunotherapy Revenue (Million USD) and Growth Rate (2016-2027)
Figure Germany Allergy Immunotherapy Revenue (Million USD) and Growth Rate (2016-2027)
Figure France Allergy Immunotherapy Revenue (Million USD) and Growth Rate (2016-2027)
Figure UK Allergy Immunotherapy Revenue (Million USD) and Growth Rate (2016-2027)
Figure Russia Allergy Immunotherapy Revenue (Million USD) and Growth Rate (2016-2027)
Figure Italy Allergy Immunotherapy Revenue (Million USD) and Growth Rate (2016-2027)
Figure Rest of Europe Allergy Immunotherapy Revenue (Million USD) and Growth Rate (2016-2027)
Figure China Allergy Immunotherapy Revenue (Million USD) and Growth Rate (2016-2027)
Figure Japan Allergy Immunotherapy Revenue (Million USD) and Growth Rate (2016-2027)
Figure Korea Allergy Immunotherapy Revenue (Million USD) and Growth Rate (2016-2027)
Figure India Allergy Immunotherapy Revenue (Million USD) and Growth Rate (2016-2027)
Figure Southeast Asia Allergy Immunotherapy Revenue (Million USD) and Growth Rate (2016-2027)
Figure Rest of Asia-Pacific Allergy Immunotherapy Revenue (Million USD) and Growth Rate (2016-2027)
Figure Brazil Allergy Immunotherapy Revenue (Million USD) and Growth Rate (2016-2027)
Figure Argentina Allergy Immunotherapy Revenue (Million USD) and Growth Rate (2016-2027)
Figure Columbia Allergy Immunotherapy Revenue (Million USD) and Growth Rate (2016-2027)
Figure Rest of South America Allergy Immunotherapy Revenue (Million USD) and Growth Rate (2016-2027)
Figure Saudi Arabia Allergy Immunotherapy Revenue (Million USD) and Growth Rate (2016-2027)
Figure United Arab Emirates Allergy Immunotherapy Revenue (Million USD) and Growth Rate (2016-2027)
Figure Egypt Allergy Immunotherapy Revenue (Million USD) and Growth Rate (2016-2027)
Figure Nigeria Allergy Immunotherapy Revenue (Million USD) and Growth Rate (2016-2027)
Figure South Africa Allergy Immunotherapy Revenue (Million USD) and Growth Rate (2016-2027)
Figure Turkey Allergy Immunotherapy Revenue (Million USD) and Growth Rate (2016-2027)
Figure Rest of Middle East and Africa Allergy Immunotherapy Revenue (Million USD) and Growth Rate (2016-2027)
Table Global Allergy Immunotherapy Revenue and Revenue Share by Type (2016-2019)
Figure Global Subcutaneous Immunotherapy (SCIT) Revenue and Growth Rate (2016-2019)
Figure Global Sublingual Immunotherapy (SLIT) Revenue and Growth Rate (2016-2019)
Table Global Allergy Immunotherapy Revenue and Revenue Share by Distribution Channel (2016-2019)
Figure Global Hospital Pharmacy Revenue and Growth Rate (2016-2019)
Figure Global Retail Pharmacy Revenue and Growth Rate (2016-2019)
Figure Global Online Pharmacy Revenue and Growth Rate (2016-2019)
Table Global Allergy Immunotherapy Revenue by Regions (2016-2019)
Figure North America Allergy Immunotherapy Growth Rate (2016-2019)
Figure North America Allergy Immunotherapy Revenue and Growth Rate (2016-2019)
Figure North America Allergy Immunotherapy by Countries (2016-2019)
Figure North America Allergy Immunotherapy Revenue (Million USD) by Countries (2016-2019)
Figure United States Allergy Immunotherapy Growth Rate (2016-2019)
Figure United States Allergy Immunotherapy Revenue (Millions USD) and Growth Rate (2016-2019)
Figure Canada Allergy Immunotherapy Growth Rate (2016-2019)
Figure Canada Allergy Immunotherapy Revenue (Millions USD) and Growth Rate (2016-2019)
Figure Mexico Allergy Immunotherapy Growth Rate (2016-2019)
Figure Mexico Allergy Immunotherapy Revenue (Millions USD) and Growth Rate (2016-2019)
Figure Europe Allergy Immunotherapy Growth Rate (2016-2019)
Figure Europe Allergy Immunotherapy Revenue and Growth Rate (2016-2019)
Figure Europe Allergy Immunotherapy by Countries (2016-2019)
Figure Europe Allergy Immunotherapy Revenue (Million USD) by Countries (2016-2019)
Figure Germany Allergy Immunotherapy Growth Rate (2016-2019)
Figure Germany Allergy Immunotherapy Revenue (Millions USD) and Growth Rate (2016-2019)
Figure France Allergy Immunotherapy Growth Rate (2016-2019)
Figure France Allergy Immunotherapy Revenue (Millions USD) and Growth Rate (2016-2019)
Figure UK Allergy Immunotherapy Growth Rate (2016-2019)
Figure UK Allergy Immunotherapy Revenue (Millions USD) and Growth Rate (2016-2019)
Figure Russia Allergy Immunotherapy Growth Rate (2016-2019)
Figure Russia Allergy Immunotherapy Revenue (Millions USD) and Growth Rate (2016-2019)
Figure Italy Allergy Immunotherapy Growth Rate (2016-2019)
Figure Italy Allergy Immunotherapy Revenue (Millions USD) and Growth Rate (2016-2019)
Figure Rest of Europe Allergy Immunotherapy Growth Rate (2016-2019)
Figure Rest of Europe Allergy Immunotherapy Revenue (Millions USD) and Growth Rate (2016-2019)
Figure Asia-Pacific Allergy Immunotherapy Growth Rate (2016-2019)
Figure Asia-Pacific Allergy Immunotherapy Revenue and Growth Rate (2016-2019)
Figure Asia-Pacific Allergy Immunotherapy by Countries (2016-2019)
Figure Asia-Pacific Allergy Immunotherapy Revenue (Million USD) by Countries (2016-2019)
Figure China Allergy Immunotherapy Growth Rate (2016-2019)
Figure China Allergy Immunotherapy Revenue (Millions USD) and Growth Rate (2016-2019)
Figure Japan Allergy Immunotherapy Growth Rate (2016-2019)
Figure Japan Allergy Immunotherapy Revenue (Millions USD) and Growth Rate (2016-2019)
Figure Korea Allergy Immunotherapy Growth Rate (2016-2019)
Figure Korea Allergy Immunotherapy Revenue (Millions USD) and Growth Rate (2016-2019)
Figure India Allergy Immunotherapy Growth Rate (2016-2019)
Figure India Allergy Immunotherapy Revenue (Millions USD) and Growth Rate (2016-2019)
Figure Southeast Asia Allergy Immunotherapy Growth Rate (2016-2019)
Figure Southeast Asia Allergy Immunotherapy Revenue (Millions USD) and Growth Rate (2016-2019)
Figure Rest of Asia-Pacific Allergy Immunotherapy Growth Rate (2016-2019)
Figure Rest of Asia-Pacific Allergy Immunotherapy Revenue (Millions USD) and Growth Rate (2016-2019)
Figure South America Allergy Immunotherapy Growth Rate (2016-2019)
Figure South America Allergy Immunotherapy Revenue and Growth Rate (2016-2019)
Figure South America Allergy Immunotherapy by Countries (2016-2019)
Figure South America Allergy Immunotherapy Revenue (Million USD) by Countries (2016-2019)
Figure Brazil Allergy Immunotherapy Growth Rate (2016-2019)
Figure Brazil Allergy Immunotherapy Revenue (Millions USD) and Growth Rate (2016-2019)
Figure Argentina Allergy Immunotherapy Growth Rate (2016-2019)
Figure Argentina Allergy Immunotherapy Revenue (Millions USD) and Growth Rate (2016-2019)
Figure Columbia Allergy Immunotherapy Growth Rate (2016-2019)
Figure Columbia Allergy Immunotherapy Revenue (Millions USD) and Growth Rate (2016-2019)
Figure Rest of South America Allergy Immunotherapy Growth Rate (2016-2019)
Figure Rest of South America Allergy Immunotherapy Revenue (Millions USD) and Growth Rate (2016-2019)
Figure Middle East and Africa Allergy Immunotherapy Growth Rate (2016-2019)
Figure Middle East and Africa Allergy Immunotherapy Revenue and Growth Rate (2016-2019)
Figure Middle East and Africa Allergy Immunotherapy by Countries (2016-2019)
Figure Middle East and Africa Allergy Immunotherapy Revenue (Million USD) by Countries (2016-2019)
Figure Saudi Arabia Allergy Immunotherapy Growth Rate (2016-2019)
Figure Saudi Arabia Allergy Immunotherapy Revenue (Millions USD) and Growth Rate (2016-2019)
Figure United Arab Emirates Allergy Immunotherapy Growth Rate (2016-2019)
Figure United Arab Emirates Allergy Immunotherapy Revenue (Millions USD) and Growth Rate (2016-2019)
Figure Egypt Allergy Immunotherapy Growth Rate (2016-2019)
Figure Egypt Allergy Immunotherapy Revenue (Millions USD) and Growth Rate (2016-2019)
Figure Nigeria Allergy Immunotherapy Growth Rate (2016-2019)
Figure Nigeria Allergy Immunotherapy Revenue (Millions USD) and Growth Rate (2016-2019)
Figure South Africa Allergy Immunotherapy Growth Rate (2016-2019)
Figure South Africa Allergy Immunotherapy Revenue (Millions USD) and Growth Rate (2016-2019)
Figure Turkey Allergy Immunotherapy Growth Rate (2016-2019)
Figure Turkey Allergy Immunotherapy Revenue (Millions USD) and Growth Rate (2016-2019)
Figure Rest of Middle East and Africa Allergy Immunotherapy Growth Rate (2016-2019)
Figure Rest of Middle East and Africa Allergy Immunotherapy Revenue (Millions USD) and Growth Rate (2016-2019)
Table ASIT Biotech Allergy Immunotherapy Financial Overview
Table Circassia Allergy Immunotherapy Financial Overview
Table Mylan N.V. Allergy Immunotherapy Financial Overview
Table Adamis Pharmaceuticals Corporation Allergy Immunotherapy Financial Overview
Table Merck KGaA Allergy Immunotherapy Financial Overview
Table Stallergenes Greer plc Allergy Immunotherapy Financial Overview
Table Allergy Therapeutics Allergy Immunotherapy Financial Overview
Table ALK-Abelló A/S Allergy Immunotherapy Financial Overview
Table DESENTUM OY Allergy Immunotherapy Financial Overview
Table HAL Allergy B.V. Allergy Immunotherapy Financial Overview
Table HollisterStier Allergy Allergy Immunotherapy Financial Overview
Figure Global Allergy Immunotherapy Revenue (Millions USD) and Growth Rate (2019-2027)
Table Allergy Immunotherapy Market Forecast by Regions (2019-2027)
Figure North America Allergy Immunotherapy Market Forecast (2019-2027)
Figure United States Allergy Immunotherapy Market Forecast (2019-2027)
Figure Canada Allergy Immunotherapy Market Forecast (2019-2027)
Figure Mexico Allergy Immunotherapy Market Forecast (2019-2027)
Figure Europe Allergy Immunotherapy Market Forecast (2019-2027)
Figure Germany Allergy Immunotherapy Market Forecast (2019-2027)
Figure France Allergy Immunotherapy Market Forecast (2019-2027)
Figure UK Allergy Immunotherapy Market Forecast (2019-2027)
Figure Russia Allergy Immunotherapy Market Forecast (2019-2027)
Figure Italy Allergy Immunotherapy Market Forecast (2019-2027)
Figure Rest of Europe Allergy Immunotherapy Market Forecast (2019-2027)
Figure Asia-Pacific Allergy Immunotherapy Market Forecast (2019-2027)
Figure China Allergy Immunotherapy Market Forecast (2019-2027)
Figure Japan Allergy Immunotherapy Market Forecast (2019-2027)
Figure Korea Allergy Immunotherapy Market Forecast (2019-2027)
Figure India Allergy Immunotherapy Market Forecast (2019-2027)
Figure Southeast Asia Allergy Immunotherapy Market Forecast (2019-2027)
Figure Rest of Asia-Pacific Allergy Immunotherapy Market Forecast (2019-2027)
Figure South America Allergy Immunotherapy Market Forecast (2019-2027)
Figure Brazil Allergy Immunotherapy Market Forecast (2019-2027)
Figure Argentina Allergy Immunotherapy Market Forecast (2019-2027)
Figure Columbia Allergy Immunotherapy Market Forecast (2019-2027)
Figure Rest of South America Allergy Immunotherapy Market Forecast (2019-2027)
Figure Middle East and Africa Allergy Immunotherapy Market Forecast (2019-2027)
Figure Saudi Arabia Allergy Immunotherapy Market Forecast (2019-2027)
Figure United Arab Emirates Allergy Immunotherapy Market Forecast (2019-2027)
Figure Egypt Allergy Immunotherapy Market Forecast (2019-2027)
Figure Nigeria Allergy Immunotherapy Market Forecast (2019-2027)
Figure South Africa Allergy Immunotherapy Market Forecast (2019-2027)
Figure Turkey Allergy Immunotherapy Market Forecast (2019-2027)
Figure Rest of Middle East and Africa Allergy Immunotherapy Market Forecast (2019-2027)
Figure Global Allergy Immunotherapy Forecast by Type (2019-2027)
Figure Global Allergy Immunotherapy Market Share Forecast by Type (2019-2027)
Figure Global Allergy Immunotherapy Forecast by Type (2019-2027)
Figure Global Allergy Immunotherapy Forecast by Distribution Channel (2019-2027)
Figure Global Allergy Immunotherapy Market Share Forecast by Distribution Channel (2019-2027)
Figure Global Allergy Immunotherapy Forecast by Distribution Channel (2019-2027)

Please Note: Data related to the Companies are subject to Availability.


Research Methodology

We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.

Data Mining

Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.

Data Collection Matrix

Data Collection Matrix

Supply Side

Demand Side

Primary Data Sources

  • Manufacturers
  • Distributors & Wholesalers
  • GPOs
  • Physicians/Specialist
  • Healthcare Providers
  • Consumers

Secondary Data Sources

  • Annual Reports/SEC Filings/ Investor Presentations/ Press Releases
  • Government/Associations Publications
  • Case Studies
  • Reference Customers

 

Market Modeling and Forecasting

We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.

  • Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
  • Number of patients for particular device or medical procedure and
  • Repeated use of particular device depending on health and condition of patient
  • Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.

We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.

Data Validation

We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.

Data Triangulation

data triangulation

Industry Analysis

Qualitative Data

Quantitative Data (2017-2025)

  • Market Dynamics (Drivers, Restraints, and Challenges)
  • Industry Trend Analysis
  • Market Opportunities
  • Government Policies and Regulations, Patent Analysis, and Reimbursement Policies
  • Porter’s Five Forces and PESTLE Analysis
  • Key Developments and Competitive Landscape
  • Market Assessment and Forecast
  • Market Assessment and Forecast, By Product
  • Market Assessment and Forecast, By Technology
  • Market Assessment and Forecast, By Application
  • Market Assessment and Forecast, By End User
  • Market Assessment and Forecast, By Region/Country

License Type

For Any Assistance

*
*
*
*
*